We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Commentary | 
Larry Dossey, MD
Arch Intern Med. 2000;160(12):1735-1738. doi:10.1001/archinte.160.12.1735.

Original Investigation |  FREE
Miriam C. J. M. Sturkenboom, PhD, PharmD, MSC; Christoph R. Meier, PhD, MSC; Hershel Jick, MD; et al.
Arch Intern Med. 1999;159(5):493-497. doi:10.1001/archinte.159.5.493.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
Related JAMA Internal Medicine Collections
From The JAMA Network
JAMA Dermatology
Original Investigation  | 
Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015
Miranda E. Rosenberg, BA; Steven P. Rosenberg, MD
JAMA Dermatology
Observation  | 
Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri
Suzanne J. Tintle, MD, MPH; Julie C. Harper, MD; Guy F. Webster, MD, PhD; et al.
JAMA Dermatology
Observation  | 
Severe Acne in Female-to-Male Transgender Patients
Lucia Turrion-Merino, MD; Marta Urech-García-de-la-Vega, MD; Laura Miguel-Gomez, MD; et al.
JAMA Dermatology
Editorial  | 
K+larity for Spironolactone At Last!
Emmy M. Graber, MD, MBA